Coherus Oncology, Inc. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
Coherus Oncology, Inc. (CHRS) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $1.36 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2021-02-25
- Coherus Oncology, Inc. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2018-09-30 was -$700.00K.
- Coherus Oncology, Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2018 was $1.36M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month |
|---|---|---|
| 2018-12-31 | $1.36M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$700.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |